Profile | GDS4284 / 242648_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 2596.09 | 87 |
GSM687648 | Patient 402 control | 2355.04 | 86 |
GSM687653 | Patient 403 control | 2189.11 | 85 |
GSM687658 | Patient 404 control | 2487.88 | 87 |
GSM687663 | Patient 411 control | 1604.93 | 81 |
GSM687668 | Patient 422 control | 2002.14 | 84 |
GSM687673 | Patient 424 control | 2398.82 | 86 |
GSM687678 | Patient 425 control | 1892.32 | 83 |
GSM687683 | Patient 427 control | 2384.29 | 86 |
GSM687688 | Patient 428 control | 1547.83 | 80 |
GSM687695 | Patient 441 control | 2452.99 | 88 |
GSM687699 | Patient 443 control | 3049.66 | 89 |
GSM687704 | Patient 444 control | 1916.51 | 83 |
GSM687707 | Patient 448 control | 2240.91 | 86 |
GSM687712 | Patient 449 control | 3022.49 | 89 |
GSM687719 | Patient 450 control | 2178.3 | 85 |
GSM687724 | Patient 451 control | 1999.09 | 84 |
GSM687728 | Patient 452 control | 2682.07 | 88 |
GSM687646 | Patient 401 treated 24h | 2279.39 | 85 |
GSM687649 | Patient 402 treated 24h | 2160.89 | 85 |
GSM687665 | Patient 411 treated 24h | 1751.31 | 82 |
GSM687651 | Patient 402 treated 4 weeks | 2188.97 | 85 |
GSM687667 | Patient 411 treated 4 weeks | 1954.91 | 83 |
GSM687670 | Patient 422 treated 24h | 2057.09 | 84 |
GSM687671 | Patient 422 treated 4 weeks | 2361.99 | 86 |
GSM687654 | Patient 403 treated 24h | 2554.06 | 87 |
GSM687675 | Patient 424 treated 24h | 2444.67 | 87 |
GSM687685 | Patient 427 treated 24h | 2174.63 | 85 |
GSM687656 | Patient 403 treated 4 weeks | 1799.66 | 82 |
GSM687677 | Patient 424 treated 4 weeks | 1747.38 | 82 |
GSM687687 | Patient 427 treated 4 weeks | 2215.29 | 85 |
GSM687692 | Patient 428 treated 4h | 2235.7 | 85 |
GSM687716 | Patient 449 treated 4h | 2620.11 | 87 |
GSM687722 | Patient 450 treated 4h | 2022.09 | 84 |
GSM687680 | Patient 425 treated 24h | 2755.74 | 88 |
GSM687690 | Patient 428 treated 24h | 2326.66 | 86 |
GSM687700 | Patient 443 treated 24h | 2361.62 | 87 |
GSM687705 | Patient 444 treated 24h | 1760.71 | 82 |
GSM687714 | Patient 449 treated 24h | 3108.84 | 89 |
GSM687721 | Patient 450 treated 24h | 2116.92 | 85 |
GSM687682 | Patient 425 treated 4 weeks | 2335.08 | 86 |
GSM687694 | Patient 428 treated 4 weeks | 1857.04 | 82 |
GSM687702 | Patient 443 treated 4 weeks | 2581.72 | 87 |
GSM687718 | Patient 449 treated 4 weeks | 2906.22 | 89 |
GSM687723 | Patient 450 treated 4 weeks | 2518.4 | 87 |
GSM687661 | Patient 404 treated 4h | 2997.85 | 89 |
GSM687710 | Patient 448 treated 4h | 2353.86 | 86 |
GSM687726 | Patient 451 treated 4h | 1825.65 | 83 |
GSM687730 | Patient 452 treated 4h | 2233.96 | 87 |
GSM687660 | Patient 404 treated 24h | 7255.3 | 95 |
GSM687697 | Patient 441 treated 24h | 3497.4 | 91 |
GSM687709 | Patient 448 treated 24h | 2267.27 | 86 |
GSM687725 | Patient 451 treated 24h | 2064.42 | 85 |
GSM687729 | Patient 452 treated 24h | 3756.99 | 91 |
GSM687727 | Patient 451 treated 4 weeks | 2073.3 | 84 |
GSM687731 | Patient 452 treated 4 weeks | 2856.06 | 88 |